Search results
Kansas sues Pfizer over 'misrepresentations' and 'adverse events' of COVID-19 vaccine
FOX Business· 5 days agoThe State of Kansas has filed a lawsuit against Pfizer, Inc. for alleged consumer protection...
Kobach sues Pfizer over COVID vaccine claims
KSNW Wichita via Yahoo News· 4 days agoKansas Attorney General Kris Kobach has filed a lawsuit against Pfizer. He says the company made misleading and deceptive claims about its COVID-19 ...
Pfizer Lingers Near 11-Year Low Despite Promising Cancer Drug Updates — Is It A Sell?
Investor's Business Daily· 1 day agoPfizer is competing against GSK's Arexvy, which hit the market about the same time in 2023. Moderna...
Merck’s vaccine approval poses threat to one of Pfizer’s top-selling products
Market Watch· 4 days ago“We’ll provide protection that’s broader than anything that’s out there,” Art Hirt, senior vice...
Kansas AG joins with Texas to become second state to sue Pfizer over COVID-19 vaccine
BizPac Review· 4 days agoKansas Attorney General Kris Kobach announced on Monday that he was suing the pharmaceutical company Pfizer over the COVID-19 vaccine, becoming the second ...
Pfizer's COVID-19 Vaccine Safety Claims Under Lens, Faces Lawsuit From Kansas For Alleged Misleading...
Benzinga· 4 days agoPFE, accusing the company of violating consumer protection laws related to its COVID-19 vaccine. Kansas Attorney General Kris Kobach argues that Pfizer ...
Kansas attorney general sues Pfizer over COVID vaccine, company responds
KSNT Topeka via Yahoo News· 4 days agoRelated video: Class action lawsuits – what are they, and should you join one? TOPEKA (KSNT) –...
Column: This GOP-leaning political polling firm has turned into a purveyor of anti-vaccine...
LA Times via Yahoo News· 3 days agoThe most important is that most respondents have no way of knowing whether an acquaintance's death...
Biden admin seeks to delay releasing data on COVID vaccine reactions, report says
NBC Montana· 2 days agoThe Biden administration on Tuesday asked for a delay in releasing data on reactions to COVID-19 ...
Is Moderna Stock A Buy After Its Second-Ever Product Snags FDA Approval?
Investor's Business Daily· 1 day agoModerna will rival Pfizer and GSK, which launched their shots last year. Also, in June, Moderna and...